Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 2
1987 3
1990 1
1991 1
1992 2
1993 2
1994 3
1995 10
1996 7
1997 6
1998 10
1999 10
2000 10
2001 23
2002 17
2003 17
2004 30
2005 42
2006 29
2007 53
2008 65
2009 57
2010 64
2011 77
2012 80
2013 76
2014 72
2015 57
2016 59
2017 57
2018 56
2019 79
2020 93
2021 82
2022 37
Text availability
Article attribute
Article type
Publication date

Search Results

1,144 results
Results by year
Filters applied: . Clear all
Page 1
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
Koo BK, Kang J, Park KW, Rhee TM, Yang HM, Won KB, Rha SW, Bae JW, Lee NH, Hur SH, Yoon J, Park TH, Kim BS, Lim SW, Cho YH, Jeon DW, Kim SH, Han JK, Shin ES, Kim HS; HOST-EXAM investigators. Koo BK, et al. Among authors: park kw. Lancet. 2021 Jun 26;397(10293):2487-2496. doi: 10.1016/S0140-6736(21)01063-1. Epub 2021 May 16. Lancet. 2021. PMID: 34010616 Clinical Trial.
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S. Kandiah N, et al. Among authors: park kw. Clin Interv Aging. 2017 Apr 18;12:697-707. doi: 10.2147/CIA.S129145. eCollection 2017. Clin Interv Aging. 2017. PMID: 28458525 Free PMC article. Review.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Rhew JY, Chun KJ, Lim YH, Bong JM, Bae JW, Lee BK, Park KW; HOST-REDUCE-POLYTECH-ACS investigators. Kim HS, et al. Among authors: park kw. Lancet. 2020 Oct 10;396(10257):1079-1089. doi: 10.1016/S0140-6736(20)31791-8. Epub 2020 Aug 31. Lancet. 2020. PMID: 32882163 Clinical Trial.
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H, Koo BK, Park KW, Shin ES, Lim SW, Rha SW, Bae JW, Jeon DW, Oh SK, Hur SH, Kim BS, Lee JH, Park TH, Lee NH, Kim HS; HOST-EXAM investigators. Lee H, et al. Among authors: park kw. Am Heart J. 2017 Mar;185:17-25. doi: 10.1016/j.ahj.2016.12.001. Epub 2016 Dec 9. Am Heart J. 2017. PMID: 28267471
The link to polysulfides and their applications.
Park KW , Leitao EM . Park KW , et al. Chem Commun (Camb). 2021 Apr 4;57(26):3190-3202. doi: 10.1039/d1cc00505g. Epub 2021 Mar 15. Chem Commun (Camb). 2021. PMID: 33720262
Ethnic Differences in Oral Antithrombotic Therapy.
Cho H, Kang J, Kim HS, Park KW. Cho H, et al. Among authors: park kw. Korean Circ J. 2020 Aug;50(8):645-657. doi: 10.4070/kcj.2020.0098. Korean Circ J. 2020. PMID: 32725974 Free PMC article. Review.
1,144 results